Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Aug 15, 2023 8:54pm
121 Views
Post# 35590173

RE:RE:RE:RE:What's This ?

RE:RE:RE:RE:What's This ?All joking aside it is good to have you aboard on this adventure.  I can't agree with you more the Replicel under Lee Buckler was a virtual Ponzi Scheme where nothing ever happened but he and the Directors sucked money out of the working capital and padded their stock holdings with options and 
private placements.
I will certainly be voting some of these Directors "off the island" at the next AGM.  Especially Lee Buckler who since he left as CEO has contributed absolutly nothing but yet draws a Directors fee.
He blogs onTwitter (X) about his pet stem cell projects but nothing about anything related to Replicel's projects.
O.K. that was a bit harsh but I had to say it.

Yes, Andrew and Jamie have stepped up and have kept this company alive on our behalf. Regardless of how this goes over the next few weeks I will never fault them.
Hang in there boys as the next few weeks are going to be very interesting
<< Previous
Bullboard Posts
Next >>